Hemiparesis clinical trials
13 active trials name this condition. Describe your situation to see which ones look like a fit.
By location
- A Novel Wrist Wearable Sensor System to Promote Hemiparetic Upper Extremity Use in Subacute Stroke Survivors
- Novel Wrist Sensor System to Promote Hemiparetic Arm Use in Home Daily Life of Chronic Stroke Survivors
- Assessment of a Physio-neuro Platform (SynPhNe) for Home-based Retraining of Hand Function in Stroke Survivors
- Post Stroke Ambulation Recovery Using Robotic Exoskeletons
- Ankle Robotics After Stroke
- Improving Myoelectric Prosthetic and Orthotic Limb Control
- MyHand 2: An Active Hand Orthosis for Stroke Patients
- Human-Machine System for the H2 Lower Limb Exoskeleton
- Spinal Cord Stimulation Combined With Physical Therapy in Post-Stroke Upper-Limb Motor Hemiparesis
- Effect of Transcutaneous Electrical Nerve Stimulation on Post-stroke Patients
- Optimal Targeted High-definition Transcranial Direct Current Stimulation for Reducing Post-stroke Upper Limb Motor Impairments
- Combined Aphasia and Robot-Assisted Arm Treatment for Chronic Stroke Survivors
- Robotic Exoskeleton Assisted Gait Post Stroke
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Hemiparesis” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.